• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿富汗喀布尔注射吸毒者中的艾滋病毒、丙型肝炎和乙型肝炎感染及相关风险行为

HIV, hepatitis C, and hepatitis B infections and associated risk behavior in injection drug users, Kabul, Afghanistan.

作者信息

Todd Catherine S, Abed Abdullah M S, Strathdee Steffanie A, Scott Paul T, Botros Boulos A, Safi Naqibullah, Earhart Kenneth C

机构信息

University of California, San Diego, La Jolla, California, USA.

出版信息

Emerg Infect Dis. 2007 Sep;13(9):1327-31. doi: 10.3201/eid1309.070036.

DOI:10.3201/eid1309.070036
PMID:18252103
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2857281/
Abstract

Limited prevalence data for HIV, hepatitis B surface antigen (HBsAg), and hepatitis C virus (HCV) exist for Afghanistan. We studied a cross-sectional sample of adult injection drug users (IDUs) in Kabul, Afghanistan, from June 2005 through June 2006. Study participants completed interviewer-administered questionnaires and underwent testing for HIV, antibody to HCV, and HBsAg. Overall prevalences of HIV, HCV, and HBsAg were 3.0% (95% confidence interval [CI] 1.7%-5.1%), 36.6% (95% CI 32.2%-41.0%), and 6.5% (95% CI 4.2%-8.7%), respectively (N = 464). Among male IDUs (n = 463), risky behavior, including sharing syringes (50.4%), paying women for sex (76.2%), and having sex with men or boys (28.3%), were common. Needle sharing, injecting for > or = 3 years, and receiving injections from nonmedical providers were independently associated with increased risk for HCV infection. The high prevalence of risky behavior indicate that Kabul is at risk for an HIV epidemic. Scale-up of harm-reducing interventions is urgently needed.

摘要

阿富汗关于艾滋病毒、乙型肝炎表面抗原(HBsAg)和丙型肝炎病毒(HCV)的流行数据有限。我们于2005年6月至2006年6月对阿富汗喀布尔的成年注射吸毒者(IDU)进行了一项横断面抽样研究。研究参与者完成了由访谈员管理的问卷调查,并接受了艾滋病毒、丙型肝炎病毒抗体和HBsAg检测。艾滋病毒、丙型肝炎病毒和HBsAg的总体流行率分别为3.0%(95%置信区间[CI] 1.7%-5.1%)、36.6%(95%CI 32.2%-41.0%)和6.5%(95%CI 4.2%-8.7%)(N = 464)。在男性注射吸毒者(n = 463)中,危险行为很常见,包括共用注射器(50.4%)、花钱与女性发生性行为(76.2%)以及与男性或男孩发生性行为(28.3%)。共用针头、注射≥3年以及从非医疗提供者处接受注射与丙型肝炎病毒感染风险增加独立相关。危险行为的高流行率表明喀布尔面临艾滋病毒流行的风险。迫切需要扩大减少伤害干预措施。

相似文献

1
HIV, hepatitis C, and hepatitis B infections and associated risk behavior in injection drug users, Kabul, Afghanistan.阿富汗喀布尔注射吸毒者中的艾滋病毒、丙型肝炎和乙型肝炎感染及相关风险行为
Emerg Infect Dis. 2007 Sep;13(9):1327-31. doi: 10.3201/eid1309.070036.
2
Prevalence of HIV, hepatitis B and hepatitis C and associated risk behaviours amongst injecting drug users in three Afghan cities.在阿富汗三个城市的注射吸毒者中,艾滋病毒、乙型肝炎和丙型肝炎的流行情况以及相关的风险行为。
Int J Drug Policy. 2011 Mar;22(2):145-52. doi: 10.1016/j.drugpo.2010.10.006. Epub 2010 Dec 10.
3
Hepatitis C and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan.冲突环境下丙型肝炎和艾滋病毒的发病率以及减少伤害项目的使用情况:阿富汗喀布尔注射吸毒者的一项观察性队列研究
Harm Reduct J. 2015 Oct 16;12:22. doi: 10.1186/s12954-015-0056-z.
4
Seroprevalence and correlates of HIV, syphilis, and hepatitis B and C virus among intrapartum patients in Kabul, Afghanistan.阿富汗喀布尔分娩期患者中艾滋病毒、梅毒以及乙型和丙型肝炎病毒的血清流行率及其相关因素
BMC Infect Dis. 2008 Sep 17;8:119. doi: 10.1186/1471-2334-8-119.
5
Risk of HIV and Hepatitis B and C Over Time Among Men Who Inject Image and Performance Enhancing Drugs in England and Wales: Results From Cross-Sectional Prevalence Surveys, 1992-2013.1992 - 2013年英格兰和威尔士注射形象与性能增强药物男性人群中随时间推移感染艾滋病毒、乙型肝炎和丙型肝炎的风险:横断面患病率调查结果
J Acquir Immune Defic Syndr. 2016 Mar 1;71(3):331-7. doi: 10.1097/QAI.0000000000000835.
6
Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.注射吸毒者中人类免疫缺陷病毒、乙型肝炎病毒和丙型肝炎病毒的合并感染
J Commun Dis. 2005 Mar;37(1):73-7.
7
Risk behaviors and HIV, hepatitis B, and hepatitis C seroprevalence among injection drug users in Georgia.格鲁吉亚注射吸毒者中的风险行为及艾滋病毒、乙型肝炎和丙型肝炎血清流行率
Drug Alcohol Depend. 2006 Apr;82 Suppl 1:S35-8. doi: 10.1016/s0376-8716(06)80006-2.
8
Prevalence and correlates of HIV, syphilis, and hepatitis B and C infection and harm reduction program use among male injecting drug users in Kabul, Afghanistan: A cross-sectional assessment.在阿富汗喀布尔,男性注射吸毒者中 HIV、梅毒、乙型肝炎和丙型肝炎感染的流行情况及其相关因素和减少伤害方案的使用情况:一项横断面评估。
Harm Reduct J. 2011 Aug 25;8:22. doi: 10.1186/1477-7517-8-22.
9
Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy.意大利监狱服刑人员中HIV、HBV和HCV感染的相关因素:一项多中心研究的结果
J Med Virol. 2005 Jul;76(3):311-7. doi: 10.1002/jmv.20375.
10
High prevalence of HIV, HCV, HBV and co-infection and associated risk factors among injecting drug users in Yunnan province, China.中国云南省注射吸毒人群中 HIV、HCV、HBV 及合并感染的高流行率及相关危险因素。
PLoS One. 2012;7(8):e42937. doi: 10.1371/journal.pone.0042937. Epub 2012 Aug 16.

引用本文的文献

1
Infectious diseases in Afghanistan: Strategies for health system improvement.阿富汗的传染病:卫生系统改善策略。
Health Sci Rep. 2023 Dec 18;6(12):e1775. doi: 10.1002/hsr2.1775. eCollection 2023 Dec.
2
Seroprevalence and Associated Factors of Hepatitis B and Hepatitis C Viral Infections Among Prisoners in Tigrai, Northern Ethiopia.埃塞俄比亚北部提格雷地区囚犯中乙型肝炎和丙型肝炎病毒感染的血清流行率及相关因素
Infect Drug Resist. 2023 Jun 13;16:3743-3750. doi: 10.2147/IDR.S410017. eCollection 2023.
3
Understanding injecting drug use in Afghanistan: A scoping review.理解阿富汗的注射吸毒问题:范围综述。
Subst Abuse Treat Prev Policy. 2022 Sep 19;17(1):65. doi: 10.1186/s13011-022-00491-1.
4
Health Status of Afghan Refugees in Europe: Policy and Practice Implications for an Optimised Healthcare.欧洲阿富汗难民的健康状况:优化医疗保健的政策和实践意义。
Int J Environ Res Public Health. 2022 Jul 27;19(15):9157. doi: 10.3390/ijerph19159157.
5
Factors Associated with HIV Risk and Vulnerability Among Injecting Drug Users in Afghanistan: A Narrative Review.阿富汗注射吸毒者中与艾滋病毒风险和易感性相关的因素:叙述性综述
HIV AIDS (Auckl). 2022 Jul 23;14:331-339. doi: 10.2147/HIV.S366970. eCollection 2022.
6
Kaposi Sarcoma in Afghanistan: A Case Series from a Tertiary Referral Center.阿富汗的卡波西肉瘤:来自三级转诊中心的病例系列
Dermatopathology (Basel). 2022 Jul 15;9(3):258-270. doi: 10.3390/dermatopathology9030030.
7
Determinants of health among people who use illicit drugs in the conflict-affected countries of Afghanistan, Colombia and Myanmar: a systematic review of epidemiological evidence.阿富汗、哥伦比亚和缅甸等受冲突影响国家中使用非法药物人群的健康决定因素:流行病学证据的系统评价
Confl Health. 2022 Jul 7;16(1):39. doi: 10.1186/s13031-022-00467-9.
8
First Report from Afghanistan on the Prevalence of Blood-Borne Infections: A Retrospective Cross-Sectional Multicentre Study for an Epidemiological Assessment.阿富汗关于血源性感染患病率的首次报告:一项用于流行病学评估的回顾性横断面多中心研究
J Blood Med. 2022 Jan 7;13:45-50. doi: 10.2147/JBM.S344180. eCollection 2022.
9
Prevalence of HIV and HCV among injecting drug users in three selected WHO-EMRO countries: a meta-analysis.在三个选定的世卫组织东地中海区域国家中注射吸毒者中 HIV 和 HCV 的流行率:一项荟萃分析。
Harm Reduct J. 2021 May 27;18(1):59. doi: 10.1186/s12954-021-00505-4.
10
Female rats express heroin-induced and -conditioned suppression of peripheral nitric oxide production in response to endotoxin challenge.雌性大鼠在受到内毒素刺激时会表现出海洛因诱导和条件作用下外周一氧化氮生成的抑制。
Brain Behav Immun. 2021 Jan;91:315-323. doi: 10.1016/j.bbi.2020.10.009. Epub 2020 Oct 8.

本文引用的文献

1
Marked ethnic differences in HIV prevalence and risk behaviors among injection drug users in Dushanbe, Tajikistan, 2004.2004年塔吉克斯坦杜尚别注射吸毒者中艾滋病毒流行率和风险行为存在显著的种族差异。
Drug Alcohol Depend. 2006 Apr;82 Suppl 1:S7-14. doi: 10.1016/s0376-8716(06)80002-5.
2
High HIV prevalence and risk factors among injection drug users in Tashkent, Uzbekistan, 2003-2004.2003 - 2004年乌兹别克斯坦塔什干注射吸毒者中艾滋病毒的高流行率及风险因素
Drug Alcohol Depend. 2006 Apr;82 Suppl 1:S15-22. doi: 10.1016/s0376-8716(06)80003-7.
3
High prevalence of HIV infection associated with incarceration among community-based injecting drug users in Tehran, Iran.伊朗德黑兰社区注射吸毒者中与监禁相关的艾滋病毒感染率很高。
J Acquir Immune Defic Syndr. 2006 Jul;42(3):342-6. doi: 10.1097/01.qai.0000219785.81163.67.
4
Drug use and harm reduction in Afghanistan.阿富汗的毒品使用与危害减少
Harm Reduct J. 2005 Sep 7;2:13. doi: 10.1186/1477-7517-2-13.
5
Prevalence of and factors associated with HIV-1 infection among drug users visiting treatment centers in Tehran, Iran.伊朗德黑兰戒毒中心吸毒者中HIV-1感染的患病率及相关因素
AIDS. 2005 Apr 29;19(7):709-16. doi: 10.1097/01.aids.0000166094.24069.72.
6
HIV knowledge and risk behaviors among Pakistani and Afghani drug users in Quetta, Pakistan.巴基斯坦奎达市巴基斯坦和阿富汗吸毒者的艾滋病病毒知识与风险行为
J Acquir Immune Defic Syndr. 2003 Apr 1;32(4):394-8. doi: 10.1097/00126334-200304010-00008.
7
Transmission and prevention of HIV and sexually transmitted infections in war settings: implications for current and future armed conflicts.战争环境中艾滋病毒和性传播感染的传播与预防:对当前及未来武装冲突的影响
AIDS. 2002 Nov 22;16(17):2245-52. doi: 10.1097/00002030-200211220-00003.
8
Incarceration and risk for HIV infection among injection drug users in Bangkok.曼谷注射吸毒者的监禁情况及感染艾滋病毒的风险
J Acquir Immune Defic Syndr. 2002 Jan 1;29(1):86-94. doi: 10.1097/00126334-200201010-00012.
9
Unsafe injections and the transmission of hepatitis B and C in a periurban community in Pakistan.巴基斯坦一个城郊社区中不安全注射与乙型和丙型肝炎的传播
Bull World Health Organ. 2000;78(8):956-63.
10
Enough sterile syringes to prevent HIV transmission among injection drug users in Montreal?是否有足够的无菌注射器来预防蒙特利尔注射吸毒者中的艾滋病毒传播?
J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S57-9. doi: 10.1097/00042560-199802001-00011.